GLIX1 Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

GLIX1 General Information

Description

Provider of drug development services intended to treat glioblastoma and other cancers.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Oslo
  • Norway
Primary Industry
Drug Discovery
Corporate Office
  • Oslo
  • Norway

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GLIX1 Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore GLIX1‘s full profile, request access.

Request a free trial

GLIX1 Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore GLIX1‘s full profile, request access.

Request a free trial

GLIX1 FAQs

  • When was GLIX1 founded?

    GLIX1 was founded in 2025.

  • Where is GLIX1 headquartered?

    GLIX1 is headquartered in Oslo, Norway.

  • What industry is GLIX1 in?

    GLIX1’s primary industry is Drug Discovery.

  • Is GLIX1 a private or public company?

    GLIX1 is a Private company.

  • What is GLIX1’s current revenue?

    The current revenue for GLIX1 is .

  • Who are GLIX1’s investors?

    BioLineRx and Hemispherian have invested in GLIX1.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process